Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
暂无分享,去创建一个
J. Babb | A. Rosenkrantz | J. Melamed | S. Taneja | B. Niver | X. Kong | D. S. Berkman
[1] S. Atlas,et al. Diffusion-weighted MR of acute cerebral infarction: comparison of data processing methods. , 1998, AJNR. American journal of neuroradiology.
[2] P. Carroll,et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.
[3] S. Heiland,et al. Noise correction for the exact determination of apparent diffusion coefficients at low SNR , 2001, Magnetic resonance in medicine.
[4] Peter Gibbs,et al. Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.
[5] V. Pansadoro,et al. Prostate cancer: evaluation with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 2004, La Radiologia medica.
[6] Peter L Choyke,et al. Imaging prostate cancer: a multidisciplinary perspective. , 2007, Radiology.
[7] Anders Kristoffersen,et al. Optimal estimation of the diffusion coefficient from non-averaged and averaged noisy magnitude data. , 2007, Journal of magnetic resonance.
[8] Takeo Ishigaki,et al. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. , 2007, European journal of radiology.
[9] S. Kyriazi,et al. Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection , 2007, Acta radiologica.
[10] Masoom A Haider,et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. , 2007, AJR. American journal of roentgenology.
[11] Namkug Kim,et al. Functional MR imaging of prostate cancer. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.
[12] Byung Kwan Park,et al. Value of Diffusion-Weighted Imaging for the Prediction of Prostate Cancer Location at 3T Using a Phased-Array Coil: Preliminary Results , 2007, Investigative radiology.
[13] D. Collins,et al. Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.
[14] Masao Fukunaga,et al. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. , 2008, Radiology.
[15] D. Dearnaley,et al. Correlation of diffusion-weighted MRI with whole mount radical prostatectomy specimens. , 2008, The British journal of radiology.
[16] K. Sugimura,et al. High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio. , 2008, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[17] Deanna L Langer,et al. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. , 2008, Radiology.
[18] N. Narula,et al. Characterization of genitourinary lesions with diffusion-weighted imaging. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.
[19] S. Dymarkowski,et al. Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma , 2009, European Radiology.
[20] Baris Turkbey,et al. Imaging localized prostate cancer: current approaches and new developments. , 2009, AJR. American journal of roentgenology.
[21] H. Honda,et al. Prostate cancer detection: the value of performing an MRI before a biopsy , 2009, Acta radiologica.
[22] H. Hricak,et al. Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer. , 2009, Radiology.
[23] Junqian Xu,et al. Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans , 2009, Magnetic resonance in medicine.
[24] K. Chida,et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. , 2009, Radiology.
[25] Amita Shukla-Dave,et al. Functional magnetic resonance imaging in prostate cancer. , 2009, European urology.
[26] Peter Choyke,et al. Challenges in clinical prostate cancer: role of imaging. , 2009, AJR. American journal of roentgenology.
[27] Kyung Ah Kim,et al. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study. , 2009, Radiology.
[28] A. Thompson,et al. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters. , 2009, AJR. American journal of roentgenology.
[29] J. Machan,et al. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy. , 2010, AJR. American journal of roentgenology.
[30] C. Kim,et al. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. , 2010, AJR. American journal of roentgenology.
[31] Kazuro Sugimura,et al. Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.
[32] J. Babb,et al. Prostate cancer vs. post‐biopsy hemorrhage: Diagnosis with T2‐ and diffusion‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.
[33] J. Babb,et al. Prostate cancer: Utility of fusion of T2‐weighted and high b‐value diffusion‐weighted images for peripheral zone tumor detection and localization , 2011, Journal of magnetic resonance imaging : JMRI.
[34] T. Metens,et al. What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? , 2012, European Radiology.
[35] T. Nakazono,et al. Diffusion-weighted MR imaging in gynecologic cancers , 2011, Journal of gynecologic oncology.
[36] P Puech,et al. Detecting prostate cancer with MRI - why and how. , 2012, Diagnostic and interventional imaging.
[37] E. Sala,et al. The emerging role of diffusion-weighted MRI in prostate cancer management , 2012, Nature Reviews Urology.
[38] P. Puech,et al. Pourquoi et comment détecter le cancer de la prostate en IRM , 2012 .
[39] B. K. Park,et al. Diffusion-Weighted Magnetic Resonance Imaging for the Evaluation of Prostate Cancer: Optimal B Value at 3T , 2012, Korean journal of radiology.